Aclarion appoints greg gould as chief financial officer

Healthtech cfo with extensive public company experience building organizations for growth and value creation demonstrated success in raising capital, driving profitability, and scaling operations to $500m revenue while ensuring compliance and strengthening financial integrity broomfield, colo., sept. 03, 2025 (globe newswire) -- aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (ai) algorithms to help physicians identify the location of chronic low back pain, announced the appointment of greg gould as chief financial officer (cfo), effective immediately.
ACON Ratings Summary
ACON Quant Ranking